Filing Details
- Accession Number:
- 0001104659-24-096869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-04 16:05:15
- Reporting Period:
- 2024-09-03
- Accepted Time:
- 2024-09-04 16:05:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786966 | Badreddin Edris | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-09-03 | 12,300 | $40.11 | 237,300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-03 | 4,620 | $41.12 | 232,680 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-03 | 3,080 | $42.08 | 229,600 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.61 to $40.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.77 to $41.725. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
